I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, particularly in cutting-edge technologies and innovations in the industry. Today, we’re diving into a groundbreaking advancement in cancer treatment—a new formulation of
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, as well as a deep understanding of technological innovation in the industry. Today, we’re diving into the recent European Commission approval of Cabometyx for advanced
I'm thrilled to sit down with Ivan Kairatov, a distinguished biopharma expert with a wealth of experience in research and development, particularly in the intersection of technology and innovation in healthcare. Today, we're diving into a groundbreaking advancement in the field of neurosurgery: a
Imagine a world where a devastating condition like Parkinson’s disease (PD), which impacts millions globally with its debilitating tremors, stiffness, and slowed movements, can be detected long before symptoms disrupt daily life. This progressive neurodegenerative disorder stems from the loss of
In the rapidly evolving landscape of healthcare technology, Tempus AI (TEM) stands out as a trailblazer in precision oncology, harnessing the power of artificial intelligence to reshape how cancer is diagnosed and treated, and with a market capitalization of $12.8 billion as of the second quarter
Imagine a future where therapies for devastating diseases like cancer, diabetes, or infectious outbreaks can be developed at an unprecedented pace, saving countless lives with tailored precision. Researchers at the Massachusetts Institute of Technology (MIT) are turning this vision into reality by
